Comparing the efficacy of dexamethasone implant and anti-VEGF for the treatment of macular edema: A systematic review and meta-analysis
H Tang, J Li, Y Yuan, Y Ling, Z Mei, H Zou - Plos one, 2024 - journals.plos.org
Objectives To evaluate the clinical efficacy of dexamethasone (DEX) implant, for the
treatment of macular edema (ME) caused by retinal vein occlusion (RVO) and diabetic …
treatment of macular edema (ME) caused by retinal vein occlusion (RVO) and diabetic …
Systematic review of clinical practice guidelines for the diagnosis and management of retinal vein occlusion
J Galvez-Olortegui, R Bouchikh-El Jarroudi… - Eye, 2024 - nature.com
Background/objectives To assess the methodological quality of Clinical Practice Guidelines
(CPG) for the diagnosis and management of Retinal Vein Occlusion (RVO). Methods A …
(CPG) for the diagnosis and management of Retinal Vein Occlusion (RVO). Methods A …
United Kingdom database study of intravitreal dexamethasone implant (Ozurdex) for macular edema related to retinal vein occlusion
Purpose: To study the treatment patterns, visual outcomes and safety profile of intravitreal
dexamethasone implant (IDI) used for the treatment of macular edema secondary to retinal …
dexamethasone implant (IDI) used for the treatment of macular edema secondary to retinal …
Comparing ranibizumab, dexamethasone implant, and combined therapy for macular edema secondary to branch retinal vein occlusion: a clinical trial
L Meng, M Yang, X Jiang, Y Li, X Han - International Ophthalmology, 2024 - Springer
Background Macular edema (ME) is a common complication following branch retinal vein
occlusion (BRVO) and is also the main reason for visual impairment. This study aimed to …
occlusion (BRVO) and is also the main reason for visual impairment. This study aimed to …
Oclusión venosa retiniana: factores de riesgo, tratamiento y evolución clínica en comparación con la trombosis venosa profunda de miembros inferiores
M Martín Romero - Proyecto de investigación, 2022 - digitum.um.es
Introducción: La oclusión venosa retiniana (OVR) es una de las principales causas de
pérdida de visión en personas mayores y la segunda retinopatía vascular más frecuente …
pérdida de visión en personas mayores y la segunda retinopatía vascular más frecuente …